OCULAR THERAPEUTIX, INC (OCUL) Gross margin 2016–2025
OCULAR THERAPEUTIX, INC (OCUL) gross margin by fiscal year — reported gross profit divided by reported revenue.
87.3%FY2025 · since FY2016: 76.5% → 87.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 87.3% | -3.8 pp |
| FY2024 | 91.2% | +0.2 pp |
| FY2023 | 91.0% | -0.2 pp |
| FY2022 | 91.2% | +1.3 pp |
| FY2021 | 89.9% | +1.8 pp |
| FY2020 | 88.0% | +43.0 pp |
| FY2019 | 45.0% | -31.6 pp |
| FY2018 | 76.6% | +0.4 pp |
| FY2017 | 76.2% | -0.3 pp |
| FY2016 | 76.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More OCUL financial trends
OCUL RevenueOCUL Net incomeOCUL Net marginOCUL Gross profitOCUL Operating incomeOCUL Operating marginOCUL Operating cash flowOCUL Free cash flowOCUL Capital expendituresOCUL Return on equityOCUL Stock buybacksOCUL Dividends paidOCUL Total assetsOCUL Total liabilitiesOCUL Shareholders’ equityOCUL overview →